Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal

Pediatric Blood & Cancer
Stephen P HungerScott C Howard

Abstract

Cure rates for children with acute lymphoblastic leukemia (ALL) are 80-85% in high-income countries (HICs) in North America and Western Europe. However, cure rates are much lower in many low-income countries (LICs), where most cases of ALL occur. Over the past several decades partnerships ("twinning") between HIC and LIC pediatric oncology programs have led to major improvements in outcome for children with ALL in some LICs, often by developing time and resource intensive relationships that allow LIC centers to treat children with regimens similar or identical to those used in HICs. However, the resources are not available in most LICs to allow immediate introduction of intensive ALL treatment regimens similar to those used in HICs. With these thoughts in mind, we present a proposal for a systematic and graduated approach to ALL diagnosis, risk classification, and treatment in LICs. We have based the strategy and the proposed regimens on those developed by the Children's Cancer Group (CCG) and Children's Oncology Group (COG) over the past several decades, beginning with a first level regimen similar to CCG therapy of the early 1980s and then layering on successive treatment intensifications proven effective in randomized clinic...Continue Reading

References

Nov 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P S GaynonG H Reaman
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D G TubergenG D Hammond
Oct 26, 2001·Hematology/oncology Clinics of North America·J A Wilimas, R C Ribeiro
Aug 30, 2002·British Journal of Haematology·Tim Eden
May 27, 2004·JAMA : the Journal of the American Medical Association·Scott C HowardFrancisco Pedrosa
Mar 12, 2005·Pediatric Blood & Cancer·Ronald D BarrPeter Hesseling
Apr 5, 2005·Pediatric Blood & Cancer·Federico AntillonGiuseppe Masera
May 28, 2005·Pediatric Blood & Cancer·A J P Veerman Sumadiono
Jul 12, 2005·Pediatric Blood & Cancer·Stephen P HungerWilliam L Carroll
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Jul 25, 2006·Pediatric Blood & Cancer·Lisa AyoubScott C Howard

❮ Previous
Next ❯

Citations

Jan 9, 2013·Current Opinion in Pediatrics·Carlos Rodriguez-GalindoLindsay Frazier
Mar 31, 2012·Blood·Satish GopalRonald T Mitsuyasu
May 28, 2015·Expert Review of Hematology·Francesco CeppiValentino Conter
Jul 28, 2015·Expert Review of Hematology·Miguela A CanizaMiguel Bonilla
Jan 27, 2016·Critical Reviews in Oncology/hematology·Gevorg TamamyanMichele P Lambert
Jan 23, 2016·Pediatric Blood & Cancer·Ramandeep Singh AroraTrijn Israels
Apr 5, 2016·Hematology/oncology Clinics of North America·Leslie LehmannRonald D Barr
Aug 3, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Miguel BonillaLillian Sung
Apr 21, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Trijn IsraelsElizabeth M Molyneux
Mar 2, 2013·Pediatric Blood & Cancer·Parth S MehtaUNKNOWN Working Group on Essential Medicines of the Pediatric Oncology in Developing Countries committee of SIOP
Jan 22, 2013·Pediatric Blood & Cancer·Guillermo ChantadaUNKNOWN SIOP-PODC Graduated-Intensity Retinoblastoma Guidelines Writing Committee
Aug 14, 2012·International Journal of Cancer. Journal International Du Cancer·Roberto Rivera-LunaManuel Aguilar-Romo
Sep 17, 2013·Pediatric Blood & Cancer·Elizabeth KerstenKatherine K Matthay
May 2, 2015·Pediatric Blood & Cancer·Jane RobertsonClive Ondari
Mar 27, 2015·Pediatric Blood & Cancer·Nehal S ParikhUNKNOWN International Society of Pediatric Oncology
Oct 21, 2014·Pediatric Blood & Cancer·Patrick J Leavey
Sep 9, 2016·South Asian Journal of Cancer·Ramandeep Singh Arora, Brijesh Arora
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carlos Rodriguez-GalindoThomas Gross
Mar 1, 2017·Pediatric Blood & Cancer·Archie BleyerRonald D Barr
Jun 10, 2017·British Journal of Haematology·Elizabeth MolyneuxLorna Renner
Nov 16, 2018·Journal of Global Oncology·Claire NealTharcisse Mpunga
Sep 23, 2018·Journal of Global Oncology·Claire NealTharcisse Mpunga
Feb 13, 2016·The American Journal of Clinical Nutrition·Etan OrgelElena J Ladas
Jun 28, 2019·Journal of Global Oncology·Deogratias RuhangazaElizabeth A Morgan
May 25, 2016·The American Journal of Bioethics : AJOB·Avram DenburgSteven Joffe
Dec 26, 2018·Journal of Global Oncology·Phillip CohenNickhill Bhakta
Sep 23, 2018·Journal of Global Oncology·Solomon Tessema MemirieStéphane Verguet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.